Valuation: Pfizer Inc

Market Cap 143B 124B 115B 106B 201B 13,570B 203B 1,362B 532B 6,783B 536B 524B 22,476B P/E 2026 *
12.7x
P/E 2027 * 13.1x
Enterprise Value 192B 167B 155B 143B 270B 18,265B 273B 1,833B 716B 9,131B 721B 705B 30,254B EV / Sales 2026 *
3.11x
EV / Sales 2027 * 3.13x
Free-Float
59.05%
Yield 2026 *
6.88%
Yield 2027 * 6.94%
Manager TitleAgeSince
Chief Executive Officer 64 01/01/2019
Director of Finance/CFO 60 02/05/2022
Chief Tech/Sci/R&D Officer - 01/01/2007
Director TitleAgeSince
Director/Board Member 68 01/09/2007
Director/Board Member 62 27/09/2013
Chairman 64 01/01/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.03%-8.82%+44.73%+147.62% 1T
+0.06%-4.58%+48.80%+50.56% 613B
-0.47%-7.51%+23.45%+64.79% 433B
+0.48%-0.67%+39.13%+34.00% 350B
+0.08%-3.05%+32.29%+39.91% 292B
+2.09%-9.27%+5.42%+7.61% 239B
+1.75%-5.79%-0.39%-42.69% 206B
+3.16%-0.82%+29.12%+60.25% 204B
+0.27%-0.17%+17.09%+70.42% 163B
Average +0.87%-3.88%+26.63%+48.05% 388.94B
Weighted average by Cap. +0.49%-4.34%+33.68%+70.57%

Financials

2026 *2027 *
Net sales 61.68B 53.56B 49.94B 45.87B 86.76B 5,867B 87.71B 589B 230B 2,933B 232B 227B 9,718B 59.37B 51.55B 48.06B 44.15B 83.5B 5,647B 84.42B 567B 222B 2,823B 223B 218B 9,353B
Net income 10.63B 9.23B 8.61B 7.91B 14.96B 1,011B 15.12B 101B 39.67B 506B 39.93B 39.05B 1,675B 10.28B 8.93B 8.32B 7.65B 14.46B 978B 14.62B 98.11B 38.35B 489B 38.6B 37.76B 1,620B
Net Debt 49.36B 42.86B 39.96B 36.71B 69.43B 4,696B 70.19B 471B 184B 2,347B 185B 181B 7,777B 43.17B 37.48B 34.95B 32.1B 60.71B 4,106B 61.38B 412B 161B 2,053B 162B 159B 6,801B
Logo Pfizer Inc
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (42.9%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (28%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (26.9%); - other (2.2%). The United States accounts for 59.2% of net sales.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-